Gastrointestinal Cancer
252
52
65
101
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
33 trials with published results (13%)
Research Maturity
101 completed trials (40% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
21 terminated out of 252 trials
82.8%
-3.8% vs benchmark
4%
9 trials in Phase 3/4
33%
33 of 101 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 101 completed trials
Clinical Trials (252)
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Harvesting Cells for Experimental Cancer Treatments
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
Prospective Assessment of Alignment Between Multimodal Artificial Intelligence and Multidisciplinary Team Decisions in Gastrointestinal Oncology
Dietary Nitrate and Nitrite Intake and Phosphate Biomarkers and Risk of Chronic Diseases
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
Butyrate Yogurt for Cancer Constipation
Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy
Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
Improving Comprehensive Care of Cancer Patients
Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers
GutCheck: Optimization of a Personalized Mobile Health App for Survivors of Gastrointestinal Cancer
BOLSTER: Learning New Skills to Thrive